Markus Arzt

Array
(
    [0] => WP_Term Object
        (
            [term_id] => 1
            [name] => Associated Partner
            [slug] => associated-partner
            [term_group] => 0
            [term_taxonomy_id] => 1
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 4
            [filter] => raw
        )

    [1] => WP_Term Object
        (
            [term_id] => 5
            [name] => Attorney at Law
            [slug] => attorney-at-law
            [term_group] => 0
            [term_taxonomy_id] => 5
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 15
            [filter] => raw
        )

)

Attorney at Law

Practice area

Get in touch

Personal Assistant

Michelle Wavrouschek

About Markus Arzt

In recent years, Markus has spearheaded various large international transactions and is a respected venture capital and private equity expert.

University of Vienna, Faculty of Law (Mag. iur. 2012)

» Markus Arzt is an exceptionally experienced M&A lawyer who regularly solves difficult situations excellently due to his calm negotiation style. Believe that he is one of the rising stars in the Austrian markets and may – without any reservations – recommend him as one of the outstanding market players. «

Legal 500

Working highlights

Advising BOA Group on the sale to Silverfleet

Advising numerous renowned VC funds and business angels on investments in targeted companies

Advised Sportradar AG on the investment of CPPIB and TCV

Co-founder of the BT Nährboden program, an initiative of Brandl Talos, which - very selectively - supports promising start-ups

Advising the majority shareholders (including Farallon, Global Health Investment Fund, Adjuvent Capital, Wellington Partners, Hadean Ventures and Ventech) on the sale of the Austrian biotechnology company Themis to Merck Sharp Dohme

Advising "Ring" International Holding AG on the acquisition of Helios and the sale of its coating division to Kansai

Publications

Start-up Guide Recht Sicher Steuern, dbv Verlag | 2020 Investitionskontrolle 2.0 - neue Hürde für Venture CapitalInvestments?, p. 862, Ecolex | 2020
EU-Verschmelzungsgesetz, Verlag Österreich | 2016 Investmentfondgesetz Kommentar, Linde Verlag | 2016 Schuldverschreibungen und Genussrechte bei grenzüberschreitender Verschmelzung, p. 304-306, Ecolex | 2015

Latest insights by
Markus Arzt

BRANDL TALOS advises Austrian family office in connection with TDR Capital's investment in Popeyes® UK

Press release • Corporate Law & Transactions from Roman Rericha, Adrian Zuschmann, Markus Arzt, Julia Strimitzer

In 2021, BRANDL TALOS has advised long time client "Ring" International Holding AG in connection with its acquisition of the master franchise rights for Popeyes® for the United Kingdom and the establishment of a joint venture with Restaurant Brands International Inc., one of the world's largest quick-service restaurant companies.

BRANDL TALOS advises on sale of ready2order to Zucchetti Group

Press release • Venture Capital & Start Ups from Roman Rericha, Markus Arzt

BRANDL TALOS advised as sell-side lead counsel on the sale of ready2order GmbH, the Austrian market leader in cloud-based point-of-sale systems, to the Italian IT market leader Zucchetti.

BRANDL TALOS advises management on sale of Seven Refractories to RHI Magnesita

Press release • Corporate Law & Transactions from Roman Rericha, Markus Arzt

BRANDL TALOS advised founder and CEO Erik Zobec as well as other minority management shareholders in the course of the sale of Seven Refractories GmbH's operations in Europe, India and the US to RHI Magnesita. Closing of the approx. EUR 93m transaction is subject to customary conditions precedent and expected in the second half of 2023.